Charles River Laboratories International inc

Charles River Laboratories International, Inc. is a leading provider of research and preclinical services to help biotechnology, pharmaceutical, and other life sciences companies bring their products to market. The company is headquartered in Wilmington, Massachusetts and has more than 100 facilities around the world. Charles River Laboratories operates in three main business segments: Research Models and Services, Discovery and Safety Assessment, and Manufacturing Support.

The Research Models and Services segment provides laboratory animal models and associated services to help researchers understand disease and test new drugs. The company offers a range of products including mice, rats, guinea pigs, hamsters, and nonhuman primates. Additionally, Charles River Laboratories provides model creation and breeding, barrier and containment facilities, and research support services.

The Discovery and Safety Assessment segment offers preclinical research and safety assessment services to pharmaceutical and biotechnology companies. The company conducts studies to evaluate the safety and efficacy of potential new drugs, including toxicology studies and safety pharmacology studies. Charles River Laboratories also provides high-throughput screening services, in vitro ADME/DMPK services, and in vivo pharmacology and efficacy services.

The Manufacturing Support segment provides biologics testing services and support through end-to-end solutions to help customers get their products to market quickly and efficiently. The company offers a wide range of services including cGMP manufacturing support, viral clearance studies, and regulatory support services.

Through a combination of its diverse service offerings and global presence, Charles River Laboratories has become a trusted partner for many large and small biotechnology and pharmaceutical companies. The company is committed to making significant contributions to the development of new drugs and therapies that will help save and improve lives.